DOI · e01.org

P16 Methylation Leads to Paclitaxel Resistance of Advanced Non-Small Cell Lung Cancer

Zhaojun Liu, Hongmei Lin, Ying Gan, Chenghua Cui, Baozhen Zhang, Liankun Gu, Jing Zhou, Guangying Zhu, Dajun Deng · Journal of Cancer · 2019

  • DOI 10.7150/jca.26482
  • Publisher Ivyspring International Publisher
  • Type article
  • Issued 2019

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · article · 2019

Abstract

Paclitaxel-based chemotherapy is widely used as the first-line treatment for non-small cell lung cancer (NSCLC).However, only 20%-40% of patients have shown sensitivity to paclitaxel.This study aimed to investigate whether P16 methylation could be used to predict paclitaxel chemosensitivity of NSCLC.Advanced NSCLC (N=45) were obtained from patients who were enrolled in a phase-III randomized paclitaxel-based clinical trial.Genomic DNA samples were extracted from the biopsies prior to chemotherapy.P16 methylation was detected using MethyLight.The association between P16 methylation and the sensitivity of paclitaxel in cell lines was determined by in vitro assay using a P16-specific DNA demethylase (P16-TET) and methyltransferase (P16-Dnmt).The total response rate of the low-dose paclitaxel-based chemo-radiotherapy was significantly lower in P16 methylation-positive NSCLCs than that in the P16 methylation-negative NSCLCs (2/15 vs.

16/30: adjusted OR=0.085; 95%CI, 0.012-0.579).Results revealed that P16 demethylation significantly decreased paclitaxel resistance of lung cancer H1299 cells (IC50 values decreased from 2.15 to 1.13 µg/ml, P<0.001).In contrast, P16-specific methylation by P16-Dnmt significantly increased paclitaxel resistance of lung cancer HCC827 cells and gastric cancer BGC823 cells (IC50 values increased from 18.2 to 24.0 ng/ml and 0.18 to 0.81 µg/ml, respectively; P=0.049 and <0.001, respectively).The present results suggest that P16 methylation may lead to paclitaxel resistance and be a predictor of paclitaxel chemosensitivity of NSCLC.

Open the resolved locator · 10.7150/jca.26482

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-19 20:20 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v10p1726.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.